Paper The following article is Open access

First injector commissioning results with helium beam at MedAustron Ion Therapy Center

, , , , , and

Published under licence by IOP Publishing Ltd
, , Citation Nadia Gambino et al 2022 J. Phys.: Conf. Ser. 2244 012109 DOI 10.1088/1742-6596/2244/1/012109

1742-6596/2244/1/012109

Abstract

MedAustron is a synchrotron-based Particle Therapy Accelerator located in lower Austria which delivers clinical proton and carbon beams in the range of 62-252.7 MeV/u and 120-400 MeV/u respectively in two clinical treatment rooms. A proton Gantry was recently commissioned in a third clinical treatment room and a fourth experimental beamline is dedicated to non-clinical research activities. Within the latter, the injector commissioning has recently started for He2+ beam generation. The long-term goal is to use helium for cancer treatment due to its favourable physical and biological properties. The helium beam properties from the source up to injection further downstream into the accelerator, i.e. from the Low Energy Beam Transfer line to the Linear Accelerator are discussed in terms of beam emittance, intensity and transmission efficiency. Furthermore, a comparison with simulated data is presented.

Export citation and abstract BibTeX RIS

Content from this work may be used under the terms of the Creative Commons Attribution 3.0 licence. Any further distribution of this work must maintain attribution to the author(s) and the title of the work, journal citation and DOI.

Please wait… references are loading.
10.1088/1742-6596/2244/1/012109